Resveratrol Supplementation: Where Are We Now and Where Should We Go?

Overview

Journal Ageing Res Rev

Specialty Geriatrics

Date 2015 Jan 28

PMID 25625901

Citations 94

Authors

Marta G Novelle

Devin Wahl

Carlos Dieguez

Michel Bernier

Rafael de Cabo

Affiliations

Soon will be listed here.

Abstract

Pre-clinical findings have provided mounting evidence that resveratrol, a dietary polyphenol, may confer health benefits and protect against a variety of medical conditions and age-related complications. However, there is no consistent evidence of an increased protection against metabolic disorders and other ailments when comparing studies in laboratory animals and humans. A number of extraneous and potential confounding variables can affect the outcome of clinical research. To date, most of the studies that have investigated the effect of resveratrol administration on patient outcomes have been limited by their sample sizes. In this review, we will survey the latest advances regarding the timing, dosage, formulation, bioavailability, toxicity of resveratrol, and resveratrol-drug interactions in human studies. Moreover, the present report focuses on the actions of resveratrol treatment in combating diseases, such as cancer, diabetes, neurodegeneration, cardiovascular disease, and other age-related ailments.

Citing Articles

Resveratrol and Physical Activity: A Successful Combination for the Maintenance of Health and Wellbeing?.

Ruggiero M, Motti M, Meccariello R, Mazzeo F Nutrients. 2025; 17(5).

PMID: 40077707 PMC: 11902109. DOI: 10.3390/nu17050837.

Role of trans-resveratrol in ameliorating biochemical and molecular alterations in obese rats induced by a high fructose/fat diet.

Khamis M, Moselhy S, Rihan S Sci Rep. 2025; 15(1):7879.

PMID: 40050385 PMC: 11885455. DOI: 10.1038/s41598-025-91027-7.

Metabolomic Insights into Smoking-Induced Metabolic Dysfunctions: A Comprehensive Analysis of Lipid and Amino Acid Metabolomes.

Aslam M, Iqbal H, Ilyas K, Rehman K, Hussain A, Akash M Metabolites. 2025; 15(2).

PMID: 39997721 PMC: 11857658. DOI: 10.3390/metabo15020096.

Metabolomic Analysis and Biochemical Profiling of Cadmium-Induced Metabolic Impairment and Its Amelioration by Resveratrol.

Ilyas K, Rehman K, Iqbal H, Hussain A, Akash M, Shahid M Bioengineering (Basel). 2024; 11(11).

PMID: 39593801 PMC: 11592041. DOI: 10.3390/bioengineering11111141.

Potential of resveratrol in the treatment of systemic lupus erythematosus (Review).

Huo R, Yang Y, Huo X, Meng D, Huang R, Yang Y Mol Med Rep. 2024; 30(4).

PMID: 39155862 PMC: 11350626. DOI: 10.3892/mmr.2024.13306.

References

Carter L, DOrazio J, Pearson K . Resveratrol and cancer: focus on in vivo evidence. Endocr Relat Cancer. 2014; 21(3):R209-25. PMC: 4013237. DOI: 10.1530/ERC-13-0171. View

Howitz K, Bitterman K, Cohen H, Lamming D, Lavu S, Wood J . Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature. 2003; 425(6954):191-6. DOI: 10.1038/nature01960. View

Bhatt J, Thomas S, Nanjan M . Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res. 2012; 32(7):537-41. DOI: 10.1016/j.nutres.2012.06.003. View

Heger A, Ferk F, Nersesyan A, Szekeres T, Kundi M, Wagner K . Intake of a resveratrol-containing dietary supplement has no impact on DNA stability in healthy subjects. Mutat Res. 2012; 749(1-2):82-6. DOI: 10.1016/j.mrgentox.2012.07.005. View

Ornstrup M, Harslof T, Kjaer T, Langdahl B, Pedersen S . Resveratrol increases bone mineral density and bone alkaline phosphatase in obese men: a randomized placebo-controlled trial. J Clin Endocrinol Metab. 2014; 99(12):4720-9. DOI: 10.1210/jc.2014-2799. View

Strong R, Miller R, Astle C, Baur J, de Cabo R, Fernandez E . Evaluation of resveratrol, green tea extract, curcumin, oxaloacetic acid, and medium-chain triglyceride oil on life span of genetically heterogeneous mice. J Gerontol A Biol Sci Med Sci. 2012; 68(1):6-16. PMC: 3598361. DOI: 10.1093/gerona/gls070. View

Smoliga J, Vang O, Baur J . Challenges of translating basic research into therapeutics: resveratrol as an example. J Gerontol A Biol Sci Med Sci. 2011; 67(2):158-67. PMC: 3261440. DOI: 10.1093/gerona/glr062. View

Ponzo V, Soldati L, Bo S . Resveratrol: a supplementation for men or for mice?. J Transl Med. 2014; 12:158. PMC: 4049475. DOI: 10.1186/1479-5876-12-158. View

Wong R, Howe P, Buckley J, Coates A, Kunz I, Berry N . Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis. 2010; 21(11):851-6. DOI: 10.1016/j.numecd.2010.03.003. View

10.

Moon R, Kohn A, De Ferrari G, Kaykas A . WNT and beta-catenin signalling: diseases and therapies. Nat Rev Genet. 2004; 5(9):691-701. DOI: 10.1038/nrg1427. View

11.

Banerjee S, Bueso-Ramos C, Aggarwal B . Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9. Cancer Res. 2002; 62(17):4945-54. View

12.

Boyle J, Thompson T, Gregg E, Barker L, Williamson D . Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr. 2010; 8:29. PMC: 2984379. DOI: 10.1186/1478-7954-8-29. View

13.

Yang L, Yang L, Tian W, Li J, Liu J, Zhu M . Resveratrol plays dual roles in pancreatic cancer cells. J Cancer Res Clin Oncol. 2014; 140(5):749-55. DOI: 10.1007/s00432-014-1624-4. View

14.

Witte A, Kerti L, Margulies D, Floel A . Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. J Neurosci. 2014; 34(23):7862-70. PMC: 6608268. DOI: 10.1523/JNEUROSCI.0385-14.2014. View

15.

Boily G, He X, Pearce B, Jardine K, McBurney M . SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene. 2009; 28(32):2882-93. DOI: 10.1038/onc.2009.147. View

16.

Polonini H, Lima L, Goncalves K, Carmo A, David da Silva A, Rezende Barbosa Raposo N . Photoprotective activity of resveratrol analogues. Bioorg Med Chem. 2013; 21(4):964-8. DOI: 10.1016/j.bmc.2012.11.052. View

17.

Canto C, Jiang L, Deshmukh A, Mataki C, Coste A, Lagouge M . Interdependence of AMPK and SIRT1 for metabolic adaptation to fasting and exercise in skeletal muscle. Cell Metab. 2010; 11(3):213-9. PMC: 3616265. DOI: 10.1016/j.cmet.2010.02.006. View

18.

Wood J, Rogina B, Lavu S, Howitz K, Helfand S, Tatar M . Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature. 2004; 430(7000):686-9. DOI: 10.1038/nature02789. View

19.

Porte C, Voduc N, Zhang G, Seguin I, Tardiff D, Singhal N . Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects. Clin Pharmacokinet. 2010; 49(7):449-54. DOI: 10.2165/11531820-000000000-00000. View

20.

Sun A, Wang Q, Simonyi A, Sun G . Resveratrol as a therapeutic agent for neurodegenerative diseases. Mol Neurobiol. 2010; 41(2-3):375-83. PMC: 3076208. DOI: 10.1007/s12035-010-8111-y. View